BACKGROUND: There is limited data on prognosis after percutaneous coronary intervention (PCI) for coronary chronic total occlusions (CTO) in the era of drug-eluting stents (DES). AIMS: This study investigates the specific contribution of CTO recanalization to the survival benefit of complete revascularization. METHODS: Consecutive patients who underwent PCI of a CTO at our center between 01/2005 and 12/2013 were followed for a median of 2.6 years (interquartile range 1.1-3.1 years). All-cause mortality was compared between patients with successful and failed PCI of CTO without and with adjustment for pertinent co-variables by the Cox models. RESULTS: The study comprised 2002 patients with attempted PCI of CTO (mean age 65.2 ± 11 years, 17 % female), 82 % had multivessel disease. The CTO PCI was successful in 1662 (83 %) patients with a DES rate of 94 %. All-cause mortality was significantly lower in patients with successful PCI of CTO compared to failed PCI of CTO (15.3 vs. 25.9 % at 4 years; P < 0.001). In the multivariable model, both successful CTO PCI and complete revascularization were strong independent predictors of reduced long-term mortality (adjusted hazard ratio (HR) 0.72; 95 % confidence interval (CI) 0.53-0.97; P = 0.03 and adjusted HR 0.59; 95 % CI 0.42-0.82; P = 0.002). Also within the subset of incomplete revascularization, successful PCI of CTO was associated with reduced mortality (adjusted HR: 0.67; 95 % CI: 0.50-0.92; P = 0.012). CONCLUSION: Successful CTO recanalization is an independent predictor for improved long-term survival. Persistent CTO lesions are associated with significantly worse survival than persistent non-occlusive coronary lesions.
BACKGROUND: There is limited data on prognosis after percutaneous coronary intervention (PCI) for coronary chronic total occlusions (CTO) in the era of drug-eluting stents (DES). AIMS: This study investigates the specific contribution of CTO recanalization to the survival benefit of complete revascularization. METHODS: Consecutive patients who underwent PCI of a CTO at our center between 01/2005 and 12/2013 were followed for a median of 2.6 years (interquartile range 1.1-3.1 years). All-cause mortality was compared between patients with successful and failed PCI of CTO without and with adjustment for pertinent co-variables by the Cox models. RESULTS: The study comprised 2002 patients with attempted PCI of CTO (mean age 65.2 ± 11 years, 17 % female), 82 % had multivessel disease. The CTO PCI was successful in 1662 (83 %) patients with a DES rate of 94 %. All-cause mortality was significantly lower in patients with successful PCI of CTO compared to failed PCI of CTO (15.3 vs. 25.9 % at 4 years; P < 0.001). In the multivariable model, both successful CTO PCI and complete revascularization were strong independent predictors of reduced long-term mortality (adjusted hazard ratio (HR) 0.72; 95 % confidence interval (CI) 0.53-0.97; P = 0.03 and adjusted HR 0.59; 95 % CI 0.42-0.82; P = 0.002). Also within the subset of incomplete revascularization, successful PCI of CTO was associated with reduced mortality (adjusted HR: 0.67; 95 % CI: 0.50-0.92; P = 0.012). CONCLUSION: Successful CTO recanalization is an independent predictor for improved long-term survival. Persistent CTO lesions are associated with significantly worse survival than persistent non-occlusive coronary lesions.
Entities:
Keywords:
Chronic total occlusion; Coronary artery; Drug-eluting stent; Survival
Authors: Paul Fefer; Merril L Knudtson; Asim N Cheema; P Diane Galbraith; Azriel B Osherov; Sergey Yalonetsky; Sharon Gannot; Michelle Samuel; Max Weisbrod; Daniel Bierstone; John D Sparkes; Graham A Wright; Bradley H Strauss Journal: J Am Coll Cardiol Date: 2012-03-13 Impact factor: 24.094
Authors: Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart Journal: EuroIntervention Date: 2012-05-15 Impact factor: 6.534
Authors: Harindra C Wijeysundera; Colleen Norris; Paul Fefer; P Diane Galbraith; Merril L Knudtson; Rafael Wolff; Graham A Wright; Bradley H Strauss; Dennis T Ko Journal: EuroIntervention Date: 2014-02 Impact factor: 6.534
Authors: Vasim Farooq; Patrick W Serruys; Hector M Garcia-Garcia; Yaojun Zhang; Christos V Bourantas; David R Holmes; Michael Mack; Ted Feldman; Marie-Claude Morice; Elisabeth Ståhle; Stefan James; Antonio Colombo; Roberto Diletti; Michail I Papafaklis; Ton de Vries; Marie-Angèle Morel; Gerrit Anne van Es; Friedrich W Mohr; Keith D Dawkins; Arie-Pieter Kappetein; Georgios Sianos; Eric Boersma Journal: J Am Coll Cardiol Date: 2012-12-19 Impact factor: 24.094
Authors: Edward L Hannan; Michael Racz; David R Holmes; Spencer B King; Gary Walford; John A Ambrose; Samin Sharma; Stanley Katz; Luther T Clark; Robert H Jones Journal: Circulation Date: 2006-05-15 Impact factor: 29.690
Authors: Adrian S H Cheng; Joseph B Selvanayagam; Michael Jerosch-Herold; William J van Gaal; Theodoros D Karamitsos; Stefan Neubauer; Adrian P Banning Journal: JACC Cardiovasc Interv Date: 2008-02 Impact factor: 11.195
Authors: Sharon W Kirschbaum; Timo Baks; Martin van den Ent; George Sianos; Gabriel P Krestin; Patrick W Serruys; Pim J de Feyter; Robert-Jan M van Geuns Journal: Am J Cardiol Date: 2007-12-03 Impact factor: 2.778
Authors: Omar M Jeroudi; Mohammed E Alomar; Tesfaldet T Michael; Abdallah El Sabbagh; Vishal G Patel; Owen Mogabgab; Eric Fuh; Daniel Sherbet; Nathan Lo; Michele Roesle; Bavana V Rangan; Shuaib M Abdullah; Jeffrey L Hastings; Jerrold Grodin; Subhash Banerjee; Emmanouil S Brilakis Journal: Catheter Cardiovasc Interv Date: 2013-11-13 Impact factor: 2.692
Authors: Andrew Ladwiniec; Michael S Cunnington; Jennifer Rossington; Adam N Mather; Albert Alahmar; Richard M Oliver; Sukhjinder S Nijjer; Justin E Davies; Simon Thackray; Farquad Alamgir; Angela Hoye Journal: Circ Cardiovasc Interv Date: 2015-04 Impact factor: 6.546
Authors: Aurel Toma; Barbara E Stähli; Michael Gick; Cathérine Gebhard; Thomas Nührenberg; Kambis Mashayekhi; Miroslaw Ferenc; Franz-Josef Neumann; Heinz Joachim Buettner Journal: Clin Res Cardiol Date: 2017-02-24 Impact factor: 5.460